Eyam Health

Startup

Eyam Health is a platform biotechnology company advancing the next generation of vaccines and therapeutics through integrated design and delivery technologies. At the core of Eyam’s approach are two proprietary systems: Gemini, a self-amplifying RNA and DNA platform capable of delivering large, multi-gene payloads without lipid nanoparticles or cold-chain logistics; and Jennerator, an AI-powered bioinformatics engine that rapidly identifies and optimizes immunogenic sequences for targeted, durable interventions.

Eyam focuses on high-impact applications across infectious diseases, oncology, chronic conditions, and animal health—areas where current solutions often fall short in efficacy, accessibility, or scalability. The Gemini platform supports long-duration expression and flexible delivery formats, enabling fewer doses and broader distribution. Jennerator dramatically accelerates discovery timelines while improving precision, tailoring payloads specifically for Gemini’s delivery architecture.

Together, these platforms allow Eyam to address both known and emerging health threats with speed and precision, while reducing manufacturing complexity and distribution costs. Eyam’s active development programs span multi-pathogen vaccines, therapeutic antibodies, and next-generation biologics designed for global access. By tightly integrating computation and synthetic biology, Eyam is reshaping how medicines are designed, scaled, and deployed to meet the world’s most pressing health challenges.

website